3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
3
Active not recruiting
3
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Small Cell Lung Carcinoma
7
Carcinoma, Hepatocellular
7
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Melanoma
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Biliary Tract Neoplasms
4
Rectal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Renal Cell
3
Stomach Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Lymphoma
2
Liver Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Merkel Cell
2
Bile Duct Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Unresectable Stage III NSCLC
1
Triple Negative Breast Neoplasms
1
Resectable Biliary Tract Cancer
1
Radiation Pneumonitis
1
Interventions
Cisplatin
10
Paclitaxel
9
Radiotherapy
5
Fluorouracil
5
Radiotherapy, Intensity-Modulated
4
Docetaxel
4
Carboplatin
4
advexin
2
Therapeutics
2
Surveys and Questionnaires
2
Oxaliplatin
2
Leucovorin
2
Drug Therapy
2
Cetuximab
2
Afatinib
2
penpulimab
1
pembrolizumab
1
olaparib
1
niraparib
1
nimotuzumab
1
nedaplatin
1
durvalumab
1
daromun
1
camrelizumab
1
calcipotriene
1
atezolizumab
1
afamelanotide
1
TP protocol
1
Surgical Procedures, Operative
1
Radiotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Squamous Cell
×
durvalumab
×
Clear all
NCT03051906
2017-11-22
DUCRO-HN
Azienda Ospedaliero-Universitaria Careggi
Phase 1/2
Unknown
69 enrolled